Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxMinority InterestNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Broadway Financial (BYFC) Fed Funds Sold (2016 - 2025)

Historic Fed Funds Sold for Broadway Financial (BYFC) over the last 11 years, with Q2 2025 value amounting to $3.8 million.

  • Broadway Financial's Fed Funds Sold fell 6345.71% to $3.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.8 million, marking a year-over-year decrease of 6345.71%. This contributed to the annual value of $9.6 million for FY2024, which is 511.03% down from last year.
  • Broadway Financial's Fed Funds Sold amounted to $3.8 million in Q2 2025, which was down 6345.71% from $4.6 million recorded in Q1 2025.
  • Over the past 5 years, Broadway Financial's Fed Funds Sold peaked at $10.3 million during Q1 2024, and registered a low of $1.5 million during Q2 2022.
  • For the 5-year period, Broadway Financial's Fed Funds Sold averaged around $5.9 million, with its median value being $5.1 million (2022).
  • As far as peak fluctuations go, Broadway Financial's Fed Funds Sold soared by 52108.84% in 2023, and later crashed by 6345.71% in 2025.
  • Broadway Financial's Fed Funds Sold (Quarter) stood at $2.6 million in 2021, then soared by 115.12% to $5.5 million in 2022, then surged by 83.49% to $10.2 million in 2023, then decreased by 5.11% to $9.6 million in 2024, then plummeted by 60.97% to $3.8 million in 2025.
  • Its Fed Funds Sold was $3.8 million in Q2 2025, compared to $4.6 million in Q1 2025 and $9.6 million in Q4 2024.